Gilead Sciences Inc.GILD
Close of Friday, October 23, 2026 · Gilead Sciences Inc. is trading above its Pivot, OnlyAlpha's long-term trend line.
Price
$156.05
vs its Pivot
+12.4%
OnlyAlpha Score
66
Trend
Above its Pivot
Last 12 months. Solid line: price. Dashed green: the Pivot. ▲ closed at least 1% above the Pivot (in) · ▼ closed below it (out). Hover or drag across the chart for any day.
Returns
| 1 month | Year to date | 1 year | 3 years / yr | 5 years / yr |
|---|---|---|---|---|
| +4.2% | +29.4% | +31.7% | +29.1% | +22.5% |
Dividend: $3.25 a share over the last 12 months, a 2.08% yield at today's price.
Who runs and owns it
In these funds
IBB · 8.18%IYH · 2.93%DGRO · 0.93%DVY · 0.77%IQQ · 0.76%OEF · 0.37%
Big investors that own it (latest 13F)
| Renaissance Technologies founded by Jim Simons | 0.4% of holdings |
| Point72 Steve Cohen | 0.3% of holdings |
| Norway (Norges Bank) Norway's sovereign wealth fund | 0.3% of holdings |
| Citadel Ken Griffin | 0.3% of holdings |
| New York State Common New York State pension | 0.2% of holdings |
| CalPERS California public pension | 0.2% of holdings |
Members of Congress who traded it
| Sheldon Whitehouse D · RI | 11 buys · 6 sells · last sell 2017-09-20 |
| Ro Khanna D · CA | 8 buys · 7 sells · last sell 2026-08-10 |
| Bill Flores R · TX | 3 buys · 5 sells · last buy 2019-09-19 |
| Tommy Tuberville R · AL | 4 buys · 2 sells · last buy 2024-05-10 |
| Josh Gottheimer D · NJ | 2 buys · 3 sells · last buy 2026-01-27 |
| Lamar Smith R · TX | 1 buys · 4 sells · last sell 2016-08-16 |
| Thomas J. Rooney R · FL | 4 buys · 1 sells · last sell 2017-03-06 |
| Marjorie Taylor Greene R · GA | 4 buys · 0 sells · last buy 2025-06-06 |
Suppliers, customers and partners
Sells to GILD
| Royalty Pharma | Trodelvy, $47M |
GILD sells to
| Cardinal Health | ~90% of US gross sales combined |
| Cencora | ~90% of US gross sales combined |
| McKesson | ~90% of US gross sales combined |
| Johnson & Johnson (Janssen) | Symtuza revenue share |
Partners and deals
| Arcus Biosciences | oncology collaboration |
| Merck & Co. | oncology collaboration |
From the companies' own annual reports filed with the SEC.
Healthcare · Pharma
Get GILD in your free daily emailAfter every close: whether GILD is above or below its Pivot, its OnlyAlpha Score, and any new buy or sell signal, along with the rest of your list.
Track GILD free → Full Stock check
Track GILD free → Full Stock check